NASDAQ·US·Drug Manufacturers - General
BIIBBIIB
0คะแนน
สรุป
ปานกลาง
ความมั่นใจ 85%
$194.38—
Today's session
Upside?
+50.0%
FV $378.82
P/E (TTM)?
20.9
Earnings yield
FCF yield?
6.9%
Mcap $28.7B
ซื้อ
Fundamental buy·Technical buy
What investors notice
Key signs
Plain-language read of the metrics that matter most for this stock.
Strongly positive
6 · 1 · 2
Strengths
- Strong free-cash-flow compounding20%
- Recent growth re-accelerating
- Long-term debt declining year-over-year
- Trading well below consensus fair value50%
- High FCF yield7%
- Analyst consensus heavily Buy-skewed
Risks
- Inconsistent profitability4/10
- EPS shrinking on a 5-year basis-25%
Watchlist
- Gross margins under pressure
$194.38+61.8%
1Y · period change vs 2025-04-29
Score history (10y)
How quality has trended through cycles.
Verdict bands: 85+ Wonderful · 70 Solid · 55 Average · 40 Risky.
Fair value range
4 of 5 models · trimmed-mean consensus
Consensus FV
$378.82
Upside
+50.0%
Now $194.38
Our FV$378.82
Price$194.38
$68.12$844.24
Open the Fair Value tab to tweak WACC and growth, and to see all five model outputs side-by-side.
10-year financials
Annual revenue, profit, and free cash flow with year-over-year growth overlay.
YoY growth overlaid
Snapshot
At a glance
Top-line figures most investors check first.
Market cap
$28.7B
P/E (TTM)?
20.9
FCF yield?
6.9%
Dividend
—
52w range
$116.82 – $201.18
Score confidence
85%
Data completeness
Last updated 4/30/2026, 5:21:14 AM · Data via Yahoo Finance, FMP, EDGAR. Disclaimer